跳至主要内容
临床试验/NCT04051684
NCT04051684已完成1 期

Transverse Abdominal Plane Blocks for Bariatric Surgery Patients: A Single Blinded Randomized Controlled Study

Montefiore Medical Center1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2013年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
23
试验地点
1
主要终点
Post Operative Opioid Usage

研究概览

简要总结

Addition of transverse abdominis plane (TAP) block to general anesthesia for morbidly obese patients (BMI >35) undergoing laparoscopic bariatric surgery for weight loss will significantly reduce opioid use in the recovery room

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient must be 18 years of age or older and able to provide his or her own consent.
  • The patient is scheduled for bariatric surgery including laparoscopic gastric banding, sleeve gastrectomy, and gastric bypass.
  • The patient must be surgically and medically accepted for the procedure
  • Good functional status, ability to perform activities of daily living
  • The patients BMI > 35, no upper limit
  • Signed study specific informed consent prior to enrollment

排除标准

  • Patients with an allergy to local anesthetics
  • Patients diagnosed with peripheral neuropathies including diabetes mellitus.
  • Patients with BMI <35
  • Patients with significant coronary artery disease
  • Patient refusal of block procedure.
  • Patients with chronic pain
  • Patients on pre-operative maintenance narcotics
  • American Society of Anesthesiologist classification system 4 (ASA 4) patients

研究组 & 干预措施

TAP, Bupivacaine

Experimental

This group will receive general anesthesia and at the end of the operation, but still in the operating room, a single shot TAP block with 0.5% ropivacaine 15-20 ml / side under ultrasound guided technique with blunt tipped, 21 gauge needle.

干预措施: Transverse abdominal plane block (Procedure)

TAP, Bupivacaine

Experimental

This group will receive general anesthesia and at the end of the operation, but still in the operating room, a single shot TAP block with 0.5% ropivacaine 15-20 ml / side under ultrasound guided technique with blunt tipped, 21 gauge needle.

干预措施: Ropivacaine (Drug)

结局指标

主要结局

Post Operative Opioid Usage

时间窗: 24 hour after surgery

The amounts of opioids used by the patient will be collected by a person blinded to the allocation group

次要结局

  • Nausea: The Number of Participants Experiencing Nausea Will be Assessed by Chart Review(Up to 5 hours)
  • Pain Score Assessed With Visual Analog Score (VAS)(30 minutes within arrival to PACU)
  • Vomiting: The Number of Participants Experiencing Vomiting Will be Assessed by Chart Review(Up to 5 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karina Gritsenko

Assistant Professor

Montefiore Medical Center

研究点 (1)

Loading locations...

相似试验